Cutaquig
immunoglobulin G · Solution · Subcutaneous
No FDA structured label text is available for Cutaquig. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Human Immunoglobulin G in 7 products
Cutaquig NDC products (7)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 68982-810 | Human Immunoglobulin G 165 mg/mL Solution | Octapharma USA Inc | BLA |
| 0069-1061 | Human Immunoglobulin G 165 mg/mL Solution | Pfizer Laboratories Div Pfizer Inc | BLA |
| 0069-1476 | Human Immunoglobulin G 165 mg/mL Solution | Pfizer Laboratories Div Pfizer Inc | BLA |
| 0069-1509 | Human Immunoglobulin G 165 mg/mL Solution | Pfizer Laboratories Div Pfizer Inc | BLA |
| 0069-1802 | Human Immunoglobulin G 165 mg/mL Solution | Pfizer Laboratories Div Pfizer Inc | BLA |
| 0069-1960 | Human Immunoglobulin G 165 mg/mL Solution | Pfizer Laboratories Div Pfizer Inc | BLA |
| 0069-1965 | Human Immunoglobulin G 165 mg/mL Solution | Pfizer Laboratories Div Pfizer Inc | BLA |
Frequently asked questions
Who makes Cutaquig?
Cutaquig is listed by 2 labelers in the FDA NDC directory, including Octapharma USA Inc, Pfizer Laboratories Div Pfizer Inc.